Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells

Endocrinology
A ParkerD R Clemmons

Abstract

Smooth muscle cells (SMC) secrete insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) and an IGFBP-4 protease. The purpose of this study was to determine the characteristics of this IGFBP-4 protease and to compare its inhibitor profile to those of IGFBP-5 and IGFBP-2 proteases, which are also present in SMC-conditioned medium. Cultured SMC were exposed to serum-free medium for periods of 24-72 h, and the amount of proteolytic activity in the conditioned medium was assessed by its capacity to degrade pure IGFBP-4. Minimal activity (e.g. < 20% of IGFBP-4 degraded in 24 h at 37 C) was present in conditioned medium unless IGF-I or IGF-II was added. This resulted in more than 60% of the intact IGFBP-4 being degraded in 14 h. The activity was a calcium-dependent serine protease and was inhibited by EDTA or 3,4-dicloroisocoumarin. Calcium, but not zinc, could restore proteolytic activity. Heparin alone inhibited IGFBP-4 proteolysis by more than 60%. When heparin cofactor-II and antithrombin-III (AT-III) were added alone, they each had an effect. The combination of heparin plus AT-III was no more active than heparin alone, but the combination of heparin cofactor-II and heparin resulted in near complete inhibition. Peptides tha...Continue Reading

Citations

Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·J B LawrenceC A Conover
Sep 9, 2005·International Journal of Hematology·Heike WexPeter Vorwerk
Oct 6, 1999·Current Opinion in Cell Biology·C Streuli
Aug 29, 1998·Molecular and Cellular Endocrinology·D R Clemmons
May 5, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Sabine MazerbourgPhilippe Monget
Sep 22, 2010·Aging Cell·Cheryl A Conover
Apr 14, 2015·BioMed Research International·Varsha P BrahmkhatriHanudatta S Atreya
Sep 14, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Shoshana YakarDavid Clemmons
Dec 6, 2002·Endocrine Reviews·Sue M Firth, Robert C Baxter
Jul 1, 1997·Canadian Journal of Physiology and Pharmacology·M B HershensonJ Li
Nov 10, 2001·American Journal of Physiology. Endocrinology and Metabolism·L ShalamanovaT Braulke
Apr 1, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M R SchneiderE Wolf
Oct 29, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·J F Kuemmerle, B Teng
Jul 11, 2006·The Journal of Biological Chemistry·Jaroslava LieskovskaDavid R Clemmons
Apr 20, 1999·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·J B LawrenceC A Conover
Feb 13, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·D CheliusE M Spencer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.